ID

34476

Beskrivning

Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01368055

Länk

https://clinicaltrials.gov/show/NCT01368055

Nyckelord

  1. 2019-01-17 2019-01-17 -
  2. 2019-05-27 2019-05-27 -
  3. 2021-03-15 2021-03-15 - Dr. rer. medic Philipp Neuhaus
Rättsinnehavare

see on clinicaltrials.gov

Uppladdad den

17 januari 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT01368055

Eligibility Prostate Cancer NCT01368055

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
prostate cancer.
Beskrivning

ID.1

Datatyp

boolean

gleason score 2-6 or 7.
Beskrivning

ID.2

Datatyp

boolean

psa ≤ 20 ng/ml.
Beskrivning

ID.3

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous prostate cancer surgery or pelvic radiation.
Beskrivning

ID.4

Datatyp

boolean

prior/concurrent systemic chemotherapy for prostate cancer.
Beskrivning

ID.5

Datatyp

boolean

active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
Beskrivning

ID.6

Datatyp

boolean

history of hip replacement.
Beskrivning

ID.7

Datatyp

boolean

prior intrapelvic surgery.
Beskrivning

ID.8

Datatyp

boolean

taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
Beskrivning

ID.9

Datatyp

boolean

receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Prostate Cancer NCT01368055

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
prostate cancer.
boolean
ID.2
Item
gleason score 2-6 or 7.
boolean
ID.3
Item
psa ≤ 20 ng/ml.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
previous prostate cancer surgery or pelvic radiation.
boolean
ID.5
Item
prior/concurrent systemic chemotherapy for prostate cancer.
boolean
ID.6
Item
active inflammatory bowel disease (crohn's disease, diverticulitis or ulcerative colitis) affecting the rectum.
boolean
ID.7
Item
history of hip replacement.
boolean
ID.8
Item
prior intrapelvic surgery.
boolean
ID.9
Item
taking saw palmetto or methotrexate and unable or unwilling to discontinue its uses during radiation.
boolean
ID.10
Item
receiving continuous and current anticoagulation with warfarin sodium (coumadin), clopidogrel bisulfate (plavix), dabigatran etexilate mesylate (pradaxa),enoxaparin sodium (lovenox), or aspirin/er dipyridamole (aggrenox).
boolean

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial